• 52,738+ CME Conference Registrations Sold
  • 158,215+ Medical Conferences
  • 285 Specialties
  • 11,420 Organizers
  • 157,118 Speakers
  • 159 Countries
  • 4,801 Cities
Home  >  Speakers  >  Richard Samuel Finn
Richard Samuel Finn

Richard Samuel Finn

    MD
Assistant Professor | Santa Monica, California    United States of America
Haematology, Internal Medicine
Oncology, Hematology,...More
Spoken at 11 events

Biography :

Dr. Richard Finn is an Assistant Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/ Oncology. He was an undergraduate at UCLA where he was involved with early laboratory studies investigating the HER2 oncogene and the development of monoclonal antibodies to this target in breast cancer with Dr. Dennis Slamon.

He participated in the pre-clinical studies that defined the clinical candidate that eventually humanized and became the FDA approved agent trastuzumab (Herceptin). He went on to medical school at USC then returned to UCLA for his clinical training in Internal Medicine and then Hematology/ Oncology.

*********************
************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Haematology, Internal Medicine

Interested Topics

Oncology, Hematology, Internal Medicine, Advanced Malignancies

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.